FA
CMD

FDx Advisors’s Cantel Medical Corporation CMD Stock Holding History

FDx Advisors’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,001
Closed -$214K – 956
2016
Q1 		$214K Buy
+3,001
New +$188K 0.01% 833

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FDx Advisors's CMD Position: Q2 2016 in Review

FDx Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2016, closing a stake of 3,001 shares — an estimated $214K sold.

FDx Advisors first reported a position in CMD in Q1 2016 and held it in 1 quarter. The position peaked at $214K in Q1 2016. 231 funds tracked by Wall St. Rank hold CMD as of Q2 2016.

  • FDx Advisors reported no remaining Cantel Medical Corporation position as of Q2 2016 after selling out during the quarter.
  • FDx Advisors sold 3,001 Cantel Medical Corporation shares in Q2 2016, an estimated $214K.
  • FDx Advisors first reported a position in Cantel Medical Corporation in Q1 2016 and held it in 1 quarter.
  • FDx Advisors's Cantel Medical Corporation position peaked at $214K in Q1 2016.
  • 231 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2016.

Based on FDx Advisors's 13F filing for Q2 2016, filed 16 Aug 2016.